Earnings Call · Q2 FY2023·2023-08-06

Q2 23EPS +39.39%·Rev n/aQ1 23EPS -100.00%*·Rev n/aQ4 22EPS -14.63%·Rev n/aQ3 22EPS +16.00%·Rev n/a⚠ consensus missing

Wave Life Sciences, Inc. WVE

Kate Rausch — Vice President of Investor Relations and Corporate Affairs

Paul Bolno — President and Chief Executive Officer

Kyle Moran — Chief Financial Officer

+15.8%1d on move date+16.1% vs SPY3d+4.9%5d+1.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WVE calls or request research access.

More WVE calls Browse calls Request research access